PCVX logo

Vaxcyte, Inc. (PCVX) EBIT

Annual EBIT:

-$463.93M-$61.66M(-15.33%)
December 31, 2024

Summary

  • As of today, PCVX annual earnings before interest & taxes is -$463.93 million, with the most recent change of -$61.66 million (-15.33%) on December 31, 2024.
  • During the last 3 years, PCVX annual EBIT has fallen by -$363.86 million (-363.60%).
  • PCVX annual EBIT is now -1477.45% below its all-time high of -$29.41 million, reached on December 31, 2018.

Performance

PCVX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

Quarterly EBIT:

-$242.38M-$16.16M(-7.14%)
September 30, 2025

Summary

  • As of today, PCVX quarterly earnings before interest & taxes is -$242.38 million, with the most recent change of -$16.16 million (-7.14%) on September 30, 2025.
  • Over the past year, PCVX quarterly EBIT has dropped by -$102.46 million (-73.22%).
  • PCVX quarterly EBIT is now -1896.54% below its all-time high of -$12.14 million, reached on September 30, 2019.

Performance

PCVX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

TTM EBIT:

-$811.56M-$102.46M(-14.45%)
September 30, 2025

Summary

  • As of today, PCVX TTM earnings before interest & taxes is -$811.56 million, with the most recent change of -$102.46 million (-14.45%) on September 30, 2025.
  • Over the past year, PCVX TTM EBIT has dropped by -$282.51 million (-53.40%).
  • PCVX TTM EBIT is now -5720.14% below its all-time high of -$13.94 million, reached on March 31, 2019.

Performance

PCVX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

PCVX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-15.3%-73.2%-53.4%
3Y3 Years-363.6%-313.8%-362.4%
5Y5 Years-823.5%-1037.5%-844.0%

PCVX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-363.6%at low-313.8%at low-362.4%at low
5Y5-Year-823.5%at low-1146.0%at low-853.3%at low
All-TimeAll-Time-1477.5%at low-1896.5%at low-5720.1%at low

PCVX EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$242.38M(-7.1%)
-$811.56M(-14.4%)
Jun 2025
-
-$226.22M(-25.1%)
-$709.11M(-11.5%)
Mar 2025
-
-$180.79M(-11.5%)
-$635.87M(-11.6%)
Dec 2024
-$463.93M(-15.3%)
-$162.17M(-15.9%)
-$569.55M(-7.7%)
Sep 2024
-
-$139.92M(+8.5%)
-$529.05M(-5.4%)
Jun 2024
-
-$152.98M(-33.6%)
-$502.15M(-15.1%)
Mar 2024
-
-$114.47M(+5.9%)
-$436.32M(-11.0%)
Dec 2023
-$402.27M(-80.0%)
-$121.68M(-7.7%)
-$393.04M(-17.3%)
Sep 2023
-
-$113.03M(-29.7%)
-$334.94M(-19.4%)
Jun 2023
-
-$87.15M(-22.4%)
-$280.49M(-16.3%)
Mar 2023
-
-$71.19M(-12.0%)
-$241.23M(-15.3%)
Dec 2022
-$223.48M
-$63.58M(-8.5%)
-$209.26M(-19.2%)
Sep 2022
-
-$58.58M(-22.3%)
-$175.53M(-22.0%)
Jun 2022
-
-$47.89M(-22.1%)
-$143.90M(-20.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$39.22M(-31.4%)
-$119.75M(-15.5%)
Dec 2021
-$100.07M(-12.2%)
-$29.85M(-10.7%)
-$103.67M(-11.1%)
Sep 2021
-
-$26.95M(-13.6%)
-$93.28M(-6.4%)
Jun 2021
-
-$23.73M(-2.5%)
-$87.63M(-2.9%)
Mar 2021
-
-$23.14M(-19.0%)
-$85.13M(+5.0%)
Dec 2020
-$89.21M(-77.6%)
-$19.45M(+8.7%)
-$89.58M(-4.2%)
Sep 2020
-
-$21.31M(-0.4%)
-$85.97M(-11.9%)
Jun 2020
-
-$21.22M(+23.1%)
-$76.80M(-13.3%)
Mar 2020
-
-$27.60M(-74.2%)
-$67.81M(-25.2%)
Dec 2019
-$50.23M(-70.8%)
-$15.84M(-30.5%)
-$54.16M(-41.3%)
Sep 2019
-
-$12.14M(+0.8%)
-$38.32M(-46.4%)
Jun 2019
-
-$12.23M(+12.3%)
-$26.18M(-87.7%)
Mar 2019
-
-$13.94M
-$13.94M
Dec 2018
-$29.41M
-
-

FAQ

  • What is Vaxcyte, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual EBIT year-on-year change?
  • What is Vaxcyte, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly EBIT year-on-year change?
  • What is Vaxcyte, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM EBIT year-on-year change?

What is Vaxcyte, Inc. annual earnings before interest & taxes?

The current annual EBIT of PCVX is -$463.93M

What is the all-time high annual EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual earnings before interest & taxes is -$29.41M

What is Vaxcyte, Inc. annual EBIT year-on-year change?

Over the past year, PCVX annual earnings before interest & taxes has changed by -$61.66M (-15.33%)

What is Vaxcyte, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of PCVX is -$242.38M

What is the all-time high quarterly EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly earnings before interest & taxes is -$12.14M

What is Vaxcyte, Inc. quarterly EBIT year-on-year change?

Over the past year, PCVX quarterly earnings before interest & taxes has changed by -$102.46M (-73.22%)

What is Vaxcyte, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of PCVX is -$811.56M

What is the all-time high TTM EBIT for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM earnings before interest & taxes is -$13.94M

What is Vaxcyte, Inc. TTM EBIT year-on-year change?

Over the past year, PCVX TTM earnings before interest & taxes has changed by -$282.51M (-53.40%)
On this page